Introduction

Obesity is a global health problem [1] with one quarter of the adult world population currently considered obese [2]. In the USA alone, more than one third of the population is defined as obese [3]. There are differing comorbidities associated with obesity, including hypertension, diabetes, and dyslipidemia [2, 48]. Likewise, a variety of methods are promoted to induce weight loss in adults, including diet [9, 10], exercise, and medication [11, 12] but with poor long-term results leading to weight loss and comorbidity improvement [13].

Bariatric surgery has been shown to produce greater efficacy than lifestyle modifications or medical management for the reduction of comorbid medical conditions [14]. In fact, this is a field that has advanced considerably with the development of newer techniques, modification of standard procedures, and the use of robotic technology. Laparoscopic sleeve gastrectomy (LSG) has increased in popularity over the past decade due to its safety and feasibility [1518] and is currently performed as a single-stage procedure with good outcomes [4].

The International Sleeve Gastrectomy Expert Panel Consensus Statement [5] showed 90 % of the panelists in agreement that LSG is both valid as a stand-alone procedure and as a bridge to reduce perioperative risk in patients who are considered high risk and morbidly obese. In terms of outcome, combined data from 12,799 LSG procedures showed an average length of hospital stay of 2.5 days (SD = 0.93), a conversion rate of 1.05 % (SD = 1.85), a 1.06 % leak rate, and a 0.35 % stricture rate, with a postoperative gastroesophageal reflux rate of 12.11 % (SD = 8.97) [5]. Consequently, LSG has been proposed as an effective alternative to laparoscopic Roux-en-Y gastric bypass and is associated with a relatively shorter operating time and fewer complications, with comparable clinical outcomes [4, 1924]. Many other studies have demonstrated that LSG is a safe and feasible technique resulting in a short operating time and short length of hospitalization [25]. Still, postoperative complications associated with LSG have been reported, including leaks and bleeding [26]. Long-term risks include strictures and gastroesophageal reflux [27]. Of note, there have been many recent technologic advances in new staples and new reinforcing materials that could serve to increase the safety of this procedure.

Robotic technology has also been proven to be effective in very complex abdominal cases such as Whipple procedures and extended pancreatectomies [28], liver resections [29], and achalasia [30]. It has also proven useful in revision surgeries or in patients with previous abdominal surgeries, when lyses of adhesions and a precise dissection are required [31]. Initially, the robotic approach was used in the bariatric field for biliopancreatic diversion with duodenal switch, as described by Sudan and colleagues in 2007 [32], and for gastric bypass where the leak rate and conversion to open rate was 0 % [3336].

According to Romero et al. [37], the ability to control these factors using the robot has led to decreased postoperative complications. It is also important to note, however, that robotic-assisted sleeve gastrectomy (RASG) is also associated with an increase in cost and/or time involved with the procedure [37, 38].

Many reports have been published in the literature comparing the robotic sleeve gastrectomy approach with the laparoscopic approach and have shown better results with the RASG. The objective of this study is to report our technique and outcomes associated with the minimally invasive sleeve gastrectomy.

Materials and Methods

This study is a retrospective review of a prospectively maintained database with 409 patients who underwent either a laparoscopic or robot-assisted sleeve gastrectomy by two board certified surgeons at the University of Illinois Hospital and Health Sciences System between January 2008 and December 2013. This study was conducted under Institutional Review Board approval. Two experienced laparoscopic surgeons with over 400 laparoscopic bariatric procedures performed the surgeries.

All patients met the standard eligibility criteria for bariatric surgery. Specifically, following the National Institutes of Health criteria, patients had either a body mass index (BMI) greater than 35 kg/m2 with weight loss recalcitrant to nonsurgical measures with two or more comorbidities or a BMI ≥40 kg/m2 with no comorbidities [39]. Data obtained from the electronic medical records (EMR) of the University of Illinois Hospital and Health Sciences System included age, gender, height, weight, BMI, date of birth, date and type of surgery, length of surgical procedure, size of bougie used, length of hospitalization, postoperative complications, and % excess weight loss (% EWL) at 3, 6, 9, 12, 18, 24, 36, and >36 months. Data on comorbidities including hypertension, type 2 diabetes, gastroesophageal reflux disease (GERD), dyslipidemia, and sleep apnea were also obtained via the EMR.

At the beginning of our experience, patients with BMI over 50 kg/m2 were selected to undergo a robotic approach. Later in our experience, patients with BMI <50 kg/m2 were also included according to surgeons’ preferences.

Preoperative Evaluation

Patients received a bariatric preoperative evaluation and were evaluated by the bariatric surgery team to determine eligibility. Cardiologists, pulmonologists, and endocrinologists were involved if patients presented with any pertinent risk factors.

Laparoscopic Surgical Technique

For the laparoscopic approach, trocars were placed as shown in Fig. 1. The short gastric vessels were divided 5 cm from the pylorus, all the way up to the gastroesophageal junction using the laparoscopic vessel sealing Caiman® device (Aesculap Inc, Center Valley, PA). Once the greater curvature was completely mobilized, a 36-, 38-, or 40-French bougie was introduced to tailor the sleeve. The size of the bougie was based on the surgeon’s level of experience and preference. Next, the stomach was transected and disconnected from the greater curvature starting 6 cm from the pylorus and using multiple staples reloads. The stapler reloads were reinforced using Gore Seamguard® (WL Gore & Associates Inc, Flagstaff, AZ). Finally, an upper gastrointestinal endoscopy was performed in order to control stricture, intragastric bleeding, and leaks.

Fig. 1
figure 1

Trocar placement in the laparoscopic approach: LR liver retractor. 15 15 mm trocar. C camera trocar. 12 12 mm trocar. 5 5 mm trocar

Robot-Assisted Surgical Technique

For the robotic approach, trocars were placed as shown in Fig. 2. The initial steps for setting up the RASG were similar to the LSG approach. The robot was docked cranially. Using the robotic harmonic shears, the vascular supply of the greater curvature of stomach was taken down starting about 5 cm from the pylorus and all the way up to the left crus. Once the greater curvature was completely mobilized, a 40-French bougie was introduced to tailor the sleeve. It was the surgeon’s preference to use a 40-French bougie in the robotic approach. Next, the stomach was transected and disconnected from the greater curvature, starting 6 cm from the pylorus using multiple staples reloads. The stapler reloads were reinforced using Gore Seamguard®. An upper gastrointestinal endoscopy was also performed in this approach, in order to rule out stricture, intragastric bleeding, and leaks.

Fig. 2
figure 2

Trocar placement robotic approach: LR liver retractor. C camera trocar. A assistant trocar. R1, R2, R3 robotic ports

Postoperative Management

Patients started mobilization within a few hours of the procedures. On postoperative day 1, an oral tolerance trial was performed and most patients were discharged on postoperative day 2.

Statistical Analysis

Data analyses was conducted using SPSS 19.0 (IBM, SPSS Statistics). Comparisons between the groups were performed using Student’s t test for continuous variables and Fischer’s test for discrete variables. Confidence intervals were set at 95 %, and a two-sided p value of <0.05 was considered statistically significant.

Results

Demographics and Medical Characteristics

As described in Table 1, data was collected from 339 women (83.7 %) and 70 men (16.3 %). The mean age was 41 years (range 18–70). There was no statistical difference between the two groups in terms of age (p = 0.656), but there was a significant difference in gender between the groups (p < 0.5). In terms of comorbidities, 50.6 % of patients had hypertension, 34.7 % had type 2 diabetes, 32.2 % had sleep apnea, 21.7 % had GERD, 21.5 % had dyslipidemia, 17.95 % had asthma, and 7.45 % had hypothyroidism. Patient demographics were similar between the two groups (2.66 vs. 2.62, respectively; p = 0.864). Of those patients with a BMI >50 kg/m2, 48 underwent RASG and 169 underwent LSG.

Table 1 Preoperative patient demographics and comorbidities

Perioperative and Postoperative Results

Table 2 summarizes the perioperative and postoperative results. There were 105 RASG and 304 LSG procedures performed. The mean operative time in the RASG group was longer than the LSG group (110.6 min vs. 84.1 min), which was statistically significant (p < 0.05). With regard to bougie sizes, a 40-French bougie was used in 99 % of the RASG procedures, while in the LSG group, either 36- or 38-French bougies were used in 88.8 % of the cases (Table 2). As it relates to %EWL, for those who had a 40-Fr bougie used, the mean %EWL at 24 months follow-up was 43 %; while those who had a 36- or 38-French bougie used, the mean %EWL was 61 % (p < 0.05). At 36 and >36 months follow-up, the %EWL was significantly greater for the 36–38-Fr bougie group (Table 5).

Table 2 Perioperative parameters

Comparing % EWL at different times follow-up with patients using only 40-Fr bougie in the robotic versus laparoscopic approach, there were no significant differences between both groups (Table 6).

A hiatal hernia repair was performed in the LSG group in 45.7 % of patients as compared to 7.6 % in the RASG. This was statistically significant (p < 0.01) (Table 2). Hiatal hernia repair was not performed systematically; it was performed according to surgeons’ preferences.

In the patients classified as super obese (BMI >50 kg/m2), the mean operative time (OR) was shorter for the RASG (129 min vs. 143 min), although it was not statistically significant (Table 3). There were two complications in the laparoscopic group: one patient who presented with intraoperative bleeding that required an emergency splenectomy and another patient who had a suture leak on postoperative day 5 that required reoperation, drainage, and a stent placement. The patient recovered without any further consequences. The robotic group had no complications. The mortality rate in both groups was 0 % (Table 3). There was no significant difference in length of hospital stay. The robotic group’s stay was half a day shorter than the laparoscopic group (2.44 vs. 3.07; p > 0.62) (Table 2). Finally, no differences were noted in terms of %EWL and BMI at 3 months, 6 months, 9 months, 1 year, 2 years, and 3 years between the two groups. The mean BMI decrease was similar in both groups (Table 4) (Fig. 3).

Table 3 Operative time with different approach in super obese patients (BMI >50 kg/m2)
Table 4 Follow-up with patients according %EWL
Fig. 3
figure 3

Graphics comparing estimated weight loss between LSG and RASG in patients follow-up

Discussion

While LSG has long been considered a low-risk procedure with good results in terms of weight loss and comorbidity improvements, robotic surgery is gaining popularity in the bariatric and other fields. The robot was initially used for gastric bypass and biliopancreatic diversion, resulting in 0 % conversion and leak rates [35, 40]. It has more recently been used for sleeve gastrectomy.

RASG is particularly advantageous in the super morbidly obese cohort [15, 41, 42] and in patients with previous and extensive surgeries such as liver transplant [16], as reported by Elli and colleagues who demonstrated a better approach to adhesiolysis using the robot. Still, there is no clear identification of the best indications for use of the robotic system. In our experience with two similar groups of patients (LSG vs. RASG), we found that in the robotic group, there were no leaks, conversions, or postoperative complications, while in the laparoscopic group, there were no conversions, no mortality, and a low postoperative complication rate of 0.65 %.

Romero and colleagues compared their robotic experience (134 cases) with previously published data from 3148 LSG cases and found decreased complication rates for their robotic group. Specifically, they reported a leak rate of 0 % compared to 1.97 % in the LSG group (p = 0.101), a stricture rate of 0 % compared to 0.43 % in the LSG group (p = 0.447), a bleeding rate of 0.70 % compared to 1.21 % in the LSG group (p = 0.594), and a mortality rate of 0 % compared to 0.10 % in the LSG group (p = 0.714) [37]. It is important to note, however, that this was in part due to the sample sizes compared. In our experience and that of Romero et al., the number of patients is significantly higher for the LSG group, which may partially explain the higher numbers of complications in that group.

The operative time also appears to be a factor directly related to use of the robotic approach. In our sample, there was a significant difference in the mean operating time between the RASG and LSG (110.67 and 84.18 min, respectively). Our mean operative time was 110.67 min which is longer than that reported by other authors, including Vilallonga (108 min) [43], Romero (106 min) [37], and Diamantis (95.5 min) [42]. The robotic system also requires more instrumentation, specialized nursing, and larger operating rooms.

In the laparoscopic group, the mean operating time was 84.18 min which is shorter than that reported by Trastulli (106.5 min) [44] and Vilallonga (96.18 min) [43], even when taking patients with associated procedures into consideration (hiatal hernia in 45.7 % of LSG cases). It is also important to mention that the prevalence of hiatal hernia in the morbidly obese is nearly 40 % [45], suggesting that surgeons should evaluate whether patients need to have a hiatal hernia repair at the same time of sleeve gastrectomy, particularly if the patient has previous GERD symptoms [4648]. In the robotic group, another factor that could explain a longer operative time was related to the fact that it was used as a surgical training model, clinical fellows and residents were involved in performing the operation partially or completely increasing times.

Romero et al. [37] reported a length of stay in the robotic group of 2.2 days compared to 3.3 days in the systematic review (p = <0.005). Other groups have reported lengths of stay of 4 days [42] while other studies make no mention of stay [15, 49]. In our study, we found a difference of only half day shorter in the robotic group’s length of stay. Also in our study, the mean %EWL was similar in both groups. In the robotic group, the mean %EWL at 1 year was 48.89 % versus 52.23 % in the laparoscopic group (Table 4). These results are similar to Romero et al. [37] who reported a 57.2 % EWL at 12 months post-surgery.

Interestingly, different bougie sizes were used for each group and did seem to play a role in determining %EWL (Table 5). In the robotic group, a 40-French bougie was used while in the laparoscopic group, either a 36- or 38-French bougie was used. There were no significant differences between the two groups during the first 2 years of follow-up; however, long-term results after 2 years have shown statistical differences between the different bougie sizes in terms of %EWL (Table 5). The differences between 40-Fr bougies and 38- or 36-Fr bougies in %EWL started at 24 months follow-up. This is the time when the major differences in %EWL are reached with smaller bougie (i.e., at 24, 36, and >36 months follow-up smaller bougies have greater %EWL compared to the 40-Fr bougie group). Considering only patients using 40-Fr bougie, there were no significant differences in %EWL comparing robotic versus laparoscopic approach (Table 6)

Table 5 %EWL at different times follow-up according to bougie size
Table 6 Patients using only 40-Fr bougie comparing %EWL at different times follow-up in the robotic versus laparoscopic approach

This is an important result to consider because there is currently no consensus as to which bougie size is best for sleeve gastrectomy, regardless of approach [50]. Parikh et al. [51] reported no differences in %EWL at 36 months follow-up among patients who had different size bougies used during their procedures. Likewise, other authors [50] have reported no difference in %EWL among bougie sizes, though they did report that bougies 40-French and larger were associated with a leak rate of 0.92 %, as compared to 2.67 % for smaller bougies [49, 50]. In this study, there was no difference in leak rate among the different bougie sizes used.

As described by Vilallonga and Markar [43, 52] the cost of the robotic procedure is higher than the laparoscopic procedure, though cost was not a variable that was measured in this study.

Lastly, the mean operative time in the RASG group was shorter for the super obese patients than for those in the laparoscopic group, though it was not a statistical difference (129 vs. 143 min). In our experience, the robot seems to be useful for patients who were classified as super obese, with BMI >50 kg/m2, by decreasing the “torque effect” and technical limitations of a thick abdominal wall.

Conclusion

In conclusion, the results from this study reveal that there is no clear clinical advantage for RASG versus LSG. It is also associated to longer operative time in the RASG.

Future studies would be valuable using larger sample sizes to compare the effectiveness and long-term outcomes of the RASG procedure.